Analysis of Disease Activity Metrics in a Methotrexate Withdrawal Study among Patients with Rheumatoid Arthritis Treated with Tofacitinib plus Methotrexate

INTRODUCTION: The objective of this analysis was to assess disease activity metrics using a variety of disease outcome measures following methotrexate (MTX) withdrawal in ORAL Shift, a phase 3b/4 study of tofacitinib with/without MTX, in patients with rheumatoid arthritis (RA) achieving Clinical Dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Fleischmann, Roy, Haraoui, Boulos, Buch, Maya H., Gold, David, Sawyerr, Gosford, Shi, Harry, Diehl, Annette, Lee, Kristen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011257/
https://www.ncbi.nlm.nih.gov/pubmed/36534208
http://dx.doi.org/10.1007/s40744-022-00511-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011257/
https://www.ncbi.nlm.nih.gov/pubmed/36534208
http://dx.doi.org/10.1007/s40744-022-00511-3

Ejemplares similares